We are not against doctor; KPME Bill is in the interest of poor: Health Minister

News Network
November 16, 2017

Belagavi, Nov 16: Health Minister KR Ramesh Kumar assured the Legislative Assembly on Thursday that the government will arrive at a final decision by today evening on the controversial Karnataka Private Establishments (KPME) Bill, which doctors across the state are vehemently protesting.

"I'm meeting the Chief Minister this evening to find a solution," Kumar said, in response to the Opposition BJP highlighting deaths of patients across the state due to the shutdown of outpatient services in the wake of the doctors' strike. The BJP accused the government of being lax, holding Kumar responsible for the deaths of patients.

Kumar strongly defended the Bill and maintained it was in the interest of patients, especially the poor. "We are not against doctors, the medical profession or medical institutions," Kumar said. "No one is highlighting the death of patients when they can't afford treatment. But deaths of patients due to doctors' protest is all over the news," he rued.

The minister rejected the BJP's accusation that it was a matter of prestige for him to get the Bill passed. "The government has an open mind as far as the demands of the doctors are concerned," he said. He also denied reports that he would resign if the Bill was not passed.

Comments

FakeFeku
 - 
Thursday, 16 Nov 2017

Modiji. Learn something from Siddaramaiah. it is not like GST and Demonetisation. That everything you made for corporates.

Siddu fan
 - 
Thursday, 16 Nov 2017

Soon Feku will copy this also and implement as their fresh idea

Ganesh
 - 
Thursday, 16 Nov 2017

Doctors should cooperate with this. I think some doctors dont have any issue. The doctors who own hospitals having trouble more. because they cant charge more. Otherwise the institution may pay to the doctors who working under somebody institution. The risk is while considering the treatment refund for unsuccessfull one

Rahul
 - 
Thursday, 16 Nov 2017

Siddaramaiah govt have to see some precautions before the amendment. That is, govt should give and ensure proper facilities in Govt hospitals.. Otherwise decision will more harm us

Suresh
 - 
Thursday, 16 Nov 2017

If doctors protesting then we should also have to take strong decision of not to go private hospitals

Mohan
 - 
Thursday, 16 Nov 2017

It should be implemented 

Kumar
 - 
Thursday, 16 Nov 2017

Greedy doctors.The amendment good for poor people

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 7,2020

Bengaluru, May 7: Karnataka has revised its standard operating procedure (SOP) for international passengers. The first group of passengers will arrive in the state on May 8.

The number of categories has been reduced to two from three. Category A includes passengers symptomatic on arrival while Category B passengers are those asymptomatic on arrival. These are passengers who are either healthy or those having co-morbidities.

As per the revised SOP, the passenger will be released on the seventh day, if tested negative, to strict home quarantine for another seven days with stamping.

This norm is in contradiction to the Ministry of Home Affairs’ SOP for international passengers. As per the MHA’s SOP, the passengers (asymptomatic) will be under institutional quarantine for 14 days. Testing negative after 14 days, they will be allowed to go home and will undertake self-monitoring of their health for 14 more days.

On the contradiction, Pandey said, "We don't take chances as we rely on tests instead of just quarantining. Other states may be depending on just 14-day institutional quarantine."

"GOI SOP doesn't talk about Covid tests on international passengers. We have put an additional safety layer of three Covid tests on returnees -- one on arrival, second from 5-7 days and last on 12th day. This will ensure definite identification of positive cases even if they are asymptomatic and their subsequent treatment. We should look at the spirit behind the order," he added.

On the 14-day additional reporting period for category B, he said, "It is implied as category B patients should report to us for 14 days after their first 14-day quarantine period is over."

Medical Education Minister Dr K Sudhakar said that the State would follow the Centre’s norms.

Till Tuesday, Karnataka’s SOP had three categories. Under Category A (symptomatic), 14-day institutional quarantine at COVID-19 Health Care Centre was mandatory followed by 14-day reporting period. Under Category B (asymptomatic above 60 years with co-morbidities), seven-day institutional quarantine at hotel/hostel followed by seven-day home quarantine and 14-day reporting period had been recommended. The 14-day home quarantine and 14-day reporting period was mandatory for Category C (asymptomatic).

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 19,2020

Kasaragod, Jul 19: An accused in a case registered under the Protection of Children from Sexual Offences (Prevention) Act (POCSO) killed self minutes before being shifted to the jail on Sunday.

Police sources said the criminal, Shaiju, was admitted to Covid-19 observation ward after he was arrested and remanded to judicial custody after he was charged with a case under POCSO for unnatural sex with a neighbour boy recently.

The accused had made a similar attempt last month but was implicated in a case after his treatment.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.